Data science andartificial intelligenceare adding a new dimension to drug discovery and development, emphasizing computation and machine learning. Given this shift, pharmaceutical companies are actively building infrastructure, data, tools, and teams to bring together data scientists with biology and life science experts.

Pharma and biotech innovation offer a glimpse into how large organizations integrate AI tools and techniques with traditional subject matter experts who possess a deep understanding of the underlying problems to be solved.

Also Read

• Digital transformation at Philip Morris
• CIO strategy: Become a transformational chief information officer
• World Health Organization CIO on healthcare data, privacy, trust, and ethics

To gain an insider's perspective on how pharma companies use AI and machine learning, I invited Dr. B